Home/Filings/4/0001209191-23-016051
4//SEC Filing

Adams Chandra 4

Accession 0001209191-23-016051

CIK 0001718108other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:00 PM ET

Size

7.8 KB

Accession

0001209191-23-016051

Insider Transaction Report

Form 4
Period: 2023-03-01
Adams Chandra
Deputy GC
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-01+50,00050,000 total
    Exercise: $0.69Exp: 2033-03-01Common Stock (50,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-03-01+50,00050,000 total
    Exercise: $0.69Exp: 2033-03-01Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]The Options shall vest in full on February 8, 2024, so long as the reporting person remains an employee or other service provider of the Issuer on such date.
  • [F2]The Options shall vest in equal monthly installments over three years, so that all of the underlying shares shall be vested on February 8, 2026, so long as the reporting person remains an employee or other service provider of the Issuer on such dates.

Issuer

Surface Oncology, Inc.

CIK 0001718108

Entity typeother

Related Parties

1
  • filerCIK 0001950700

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:00 PM ET
Size
7.8 KB